CARLSBAD, Calif., Apr. 10, 2018 /PRNewswire-PRWeb/ -- Novasyte LLC has announced the creation and appointment of
Hillary's expanded role is in response to the growth of Novasyte's field action services, including the S.M.A.R.T. Recall Program and new application, Novasyte TRAK. "Hillary has been a pillar of the Novasyte family for more than eight years and has done a fantastic job in strategically developing the S.M.A.R.T. Program offering," Tim Gleeson, CEO, said. "We expect and look forward to her continued success in this new role."
As Novasyte continues to expand into the outsourced pharmaceutical services market, Ryan Jones will lead the national sales initiative. "Ryan has supported Novasyte in both independent sales and leadership functions," said Tim. "With his drive for excellence, we are confident Ryan will succeed in leading Novasyte into this new market." With more than 10 years of strategic business development management experience, Ryan has held the positions of Senior Director of Business Development and VP of Sales with Novasyte. He will be based in Dallas, Texas.
Novasyte partners with medical device, diagnostic and pharmaceutical companies, offering innovative outsourced support teams and technologies. Our flexible model enables us to build, deploy and manage teams that expand and contract to meet our clients' customer-facing needs. Program success is tracked and measured with our real-time business intelligence analytics that provide our clients with critical insights into their most important resources — their people and their customers.
SOURCE Novasyte Inc
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All